Ohki Healthcare Holdings

Basic Information

Stock Code
3417
Industry
Wholesale
Category Detail
Pharmaceuticals & Medical Products Wholesalers
Prefecture
Tokyo
Establishment Year
October 2015
Listing Year
October 2015
Official Website
http://www.ohki-net.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Alfresa Holdings, Hokuyaku Takeyama Holdings, Horii Food, Vital KSK Holdings, Cosmo Bio, Solasia Pharma, Yoshitake, Soken-sha, Medipal Holdings, Astena Holdings, Toho Holdings, KOA Shoji Holdings, Suzuken

Overview

Ohki Healthcare Holdings is a major holding company in the pharmaceutical wholesale industry established in 2015, centering its operations on pharmaceutical wholesaling with widespread expansion primarily in the Tokyo metropolitan area.

Current Situation

Ohki Healthcare Holdings records consolidated sales of approximately 286.1 billion yen and operating profit of about 3 billion yen, maintaining solid performance. Centered on its main subsidiary Ohki Co., Ltd., it specializes in pharmaceutical wholesaling including over-the-counter drugs, with a broad distribution network from Tohoku to Kyushu based in the Tokyo metropolitan area. It has established strong trading relationships with supermarkets and convenience stores, preserving competitiveness backed by stable market demand. In recent years, it has focused on expanding the handling of functional foods and improving logistics efficiency to strengthen stable supply systems. In terms of sustainability, it promotes waste reduction and resource recycling to aim for reducing environmental impact. Until 2030, its strategic goals include expanding distribution channels in the Kanto region and entering new health-related product markets. Anticipating intensified industry competition and changes in the distribution environment, it is working on efficiency improvements using IT and enhancing customer satisfaction. It aims to continue balancing stable growth with contributions to local society.

Trivia

Interesting Facts

  • Roots trace back to the long-established Ohki Gokoen Honpo founded in 1658
  • Has earned long-term trust as one of the major pharmaceutical wholesalers in the capital region
  • Major block companies such as Rohto Pharmaceutical and Toho HD are principal shareholders
  • Quickly responded to the expansion of the functional labeled food market by developing numerous products
  • Nationwide logistics bases enable broad-area delivery network
  • Deploys products compliant with the Ministry of Agriculture, Forestry and Fisheries health food system
  • Strengthens pharmaceutical wholesaling not only to pharmacies but also supermarkets and convenience stores
  • Shifted to holding company structure to enhance management efficiency and governance
  • Actively introduces IT for information management to promote digital shift
  • Pursues revenue stabilization through diversified business deployments
  • Owns health and beauty food manufacturing and sales company within the group
  • Operates extensive sales offices and logistics centers from Hokkaido to Okinawa
  • Highly evaluated in the industry for regionally close sales and meticulous service
  • Achieved stable performance through growth strategy after listing
  • Actively engages in local community contribution activities

Hidden Connections

  • Ohki Healthcare is a key wholesale partner for Rohto Pharmaceutical with deep ties.
  • Liv Laboratories, a health and beauty food company within the group, handles functional labeled foods.
  • Some logistics strategies are co-developed with major drugstore chains.
  • Establishes stable management system through capital alliances with major shareholders.
  • Strengthened fundraising capabilities through listing on the Tokyo Stock Exchange Standard Market.
  • Subsidiary Ohki has about 300 years of history and thrives as a long-established pharmaceutical wholesaler.
  • Secures preferential sales channels through transactions with major pharmaceutical manufacturers.
  • Known as a partner company supporting regional medical care nationwide.

Future Outlook

Growth Drivers

  • Increase in pharmaceutical demand due to aging society
  • Expanding functional labeled food market
  • Growing demand for health-related products from retailers
  • Strengthening cost competitiveness through logistics efficiency and IT investments
  • Market share expansion through deepening of regionally focused sales
  • Expansion of digital marketing utilization
  • Enhancing responsiveness to diversifying health consciousness
  • Advancing product development in collaboration with pharmaceutical manufacturers
  • Social demand evaluating sustainability efforts
  • Appropriate capture of generic drug market
  • Building systems flexible to regulatory environment
  • New business development in medical and health fields

Strategic Goals

  • Achieve annual pharmaceutical wholesale sales of 300 billion yen
  • Capture 30% share in the functional labeled food market
  • Full adoption of sustainable packaging materials and 20% waste reduction
  • 50% efficiency improvement through digitalization of logistics centers
  • Strengthen network by deploying new logistics bases in local areas
  • Reinforce domestic and international rollout of new health food lines
  • Aim to be a top-class sustainable company in ESG evaluation
  • Expand health promotion businesses through collaboration with local communities
  • Complete digital transformation to strengthen competitiveness
  • Optimize and expand B2B/B2C revenue ratios relative to annual sales

Business Segments

Pharmaceutical Wholesale Business

Overview
Stably supplies a wide range of pharmaceuticals to medical institutions and pharmacies.
Competitiveness
Robust distribution network in the capital region and diverse client base
Customers
  • Hospitals
  • Clinics
  • Pharmacies
  • Drugstore chains
  • Nursing facilities
Products
  • Over-the-counter drugs
  • Prescription drugs
  • Health and beauty foods
  • Hygiene products
  • Medical devices

Health-Related Product Sales

Overview
Provides health-related products to retailers to meet consumer needs.
Competitiveness
Flexibility in product lineup and logistics system
Customers
  • Supermarkets
  • Convenience stores
  • Drugstores
  • Mail-order businesses
Products
  • Over-the-counter drugs
  • Functional labeled foods
  • Cosmetics
  • Health supplements

Logistics Services

Overview
Supports supply chains through efficient pharmaceutical logistics.
Competitiveness
Nationwide logistics center network and state-of-the-art logistics equipment
Customers
  • Pharmaceutical manufacturers
  • Wholesalers
  • Retail stores
Products
  • Pharmaceutical logistics
  • Hygiene product logistics
  • Supply chain management

Health Food Manufacturing and Sales

Overview
Manufactures health-oriented foods in-house and deploys them through diverse channels.
Competitiveness
In-house development focused on safety and efficacy
Customers
  • Retailers
  • Mail-order operators
  • Exporters
Products
  • Functional health foods
  • Supplements
  • Beauty and health foods

Cosmetics Business

Overview
Plans and sells beauty-related products for the domestic market.
Competitiveness
Product development utilizing natural materials
Customers
  • Drugstores
  • Department stores
  • Online retailers
Products
  • Skin care products
  • Serums
  • Moisturizing creams

Competitive Advantage

Strengths

  • Powerful distribution network based in the capital region
  • Handling of diverse pharmaceuticals and health-related products
  • Stable major customer base and long-term contracts
  • Efficient logistics centers and delivery system
  • Business diversification through group collaboration
  • Strong brand recognition and customer trust
  • Abundant industry experience and stable management team
  • Regionally focused sales strategy
  • Active expansion into functional labeled foods
  • Compliance with laws and regulations
  • High-quality management system
  • Organizational promotion of sustainability
  • Extensive product lineup
  • Flexibility in customer service
  • Sound financial foundation

Competitive Advantages

  • Efficient business model specialized in pharmaceutical wholesaling
  • Maintains strong trading relationships with supermarkets and convenience stores
  • Deep market penetration and recognition despite regional focus
  • Rapid response possible through vertically integrated logistics services
  • Deploys functional labeled foods under own brands
  • Utilizes synergy effects with group companies
  • Industry network backed by long history
  • Owns logistics bases in the capital region and major nationwide areas
  • Sense of trust through strict compliance
  • Diverse product composition responding to customer needs
  • Achieves stable revenue structure
  • High specialized knowledge and responsiveness of employees
  • Solid growth strategy amid industry competition
  • Strong relationship building with local communities
  • Precise sales management and marketing strategy

Threats

  • Intensifying competition in the pharmaceutical wholesale market
  • Increased compliance burden due to stricter product regulations
  • Rise of generic drugs and alternatives
  • Risk of market contraction due to healthcare cost containment policies
  • Fluctuations in customer demand due to economic changes
  • Rising logistics costs
  • Offensives from new entrants
  • Supply chain risks during disasters
  • Decline in competitiveness due to lag in digitalization
  • Difficulty in securing talent due to labor shortages
  • Changes in product demand due to diversifying health consciousness
  • Strengthening of international pharmaceutical import regulations

Innovations

2024: Advanced Logistics Management System

Overview
Introduced an AI-utilizing logistics management system, significantly improving delivery efficiency.
Impact
10% reduction in transportation costs, shortened delivery lead times

2023: Expansion of Functional Labeled Food Lineup

Overview
Strengthened own-brand functional labeled food products in response to health trends.
Impact
Improved consumer awareness, 15% sales increase

2022: Launch of Sustainability Promotion Program

Overview
Started an in-house program for waste reduction and energy efficiency improvements.
Impact
15% reduction in environmental impact, cost reduction effects

2021: Introduction of Pharmaceutical Delivery Traceability

Overview
Established traceability system in pharmaceutical delivery processes to strengthen quality control.
Impact
Reduced quality complaints, enhanced regulatory compliance

Sustainability

  • Promoting improvement in recycling rate of packaging materials
  • Reducing CO2 emissions through eco-transportation
  • Regular implementation of in-house environmental education programs
  • Thorough proper disposal of expired pharmaceuticals
  • Cooperation in local community environmental protection activities
  • Promoting health management for employees
  • Expanding introduction of energy-saving facilities
  • Establishment of green procurement standards
  • Consideration of renewable energy equipment introduction
  • Continuous improvement in waste generation suppression